1. Home
  2. Live Updates
  3. Emdesivir

Live Breaking News & Updates on Emdesivir

Stay informed with the latest breaking news from Emdesivir on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Emdesivir and stay connected to the pulse of your community

Why parties ruling states with pharma units got the bulk of Rs 945 crore bonds donated by drug firms

Only states can take punitive action against firms for substandard drugs. But the BJP got donations even from firms based in non-BJP states.

Bihar , India , Himachal-pradesh , Uttar-pradesh , Karnataka , Gujarat , United-states , Telangana , Andhra-pradesh , Dahej , Malini-aisola , Rajya-sabha

Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients

Study found that the antiviral molnupiravir affects the evolution of SARS-CoV-2 in immunocompromised patients, suggesting its use modifies viral mutation patterns and may impact viral evolution.

University-of-california-santa-cruz , Lancet-microbe , California-santa-cruz , Coronavirus-disease-covid-19 , Volution , Ars , Ars-cov-2 , Oronavirus , Ovid-19 , Enome , Enomic

Proxalutamide shows promise as potential COVID-19 treatment

At the outset of the COVID pandemic, men appeared to suffer higher rates of severe illness and death, leading researchers to suspect a link between androgen receptors-;which bind to hormones like testosterone--and SARS-CoV-2 viral infection.

Michigan , United-states , Arul-chinnaiyan , Lily-ramsey , Jonathan-sexton , Michigan-center , Um-center , College-of-pharmacy , University-of-michigan-medical-school , Michigan-medicine , Translational-pathology , Endowed-professor

Michigan man suing COVID drug manufacturer after suffering two massive strokes

A Lenawee County man is suing the maker of Remdesivir and a Washtenaw County hospital after suffering two massive strokes.

Washtenaw-county , Michigan , United-states , Southfield , Ken-khara , Dan-nowacki , Gilead-sciences-inc , Lenawee-county , Ven-johnson-law , Joseph-mercy-hospital , Gilead-sciences

Intranasal inoculation study sheds light on nasal and systemic immune responses to SARS-CoV-2

Study reveals the events accompanying the COVID-19 infection cascade in the nasal mucosa and free circulation

Fotomay-shutterstock , Systemic-immune-correlates , Viral-control , Image-credit , Tissue-culture-infectious-doses , Scale-discovery , Sars , Ars-cov-2 , Ntibodies , Lood , Ell

Karnataka govt underreported 1.2 lakh COVID deaths says PAC report

The committee found that large quantities of tablet ivermectin were purchased even though WHO discredited it and ventilators given through PM Cares Fund were given to private hospitals.

Karnataka , India , Bengaluru , Himachal-pradesh , Kerala , Tamil-nadu , Bharat , Ramalinga-reddy , Basavaraj-bommai , Bharatiya-janata-party , Health-minister , Health-department

Two anti-inflammatory drugs reduce deaths in severe COVID-19 patients

Two anti-inflammatory drugs, abatacept and infliximab, reduced deaths among patients hospitalized with severe COVID-19, according to a national study led by Washington University School of Medicine in St. Louis. William G. Powderly, MD, (right) who led the large clinical trial, discusses patient conditions with Maanasi Samant, MD, in the intensive care unit at Barnes-Jewish Hospital, one of the major trial sites, during the COVID-19 pandemic.

United-states , America , Williamg-powderly , J-william-campbell , Danielle-ellis , Maanasi-samant , Administration-for-strategic-preparedness , Development-authority , Us-department-of-health , National-institutes-of-health , National-center , Translational-science-awards-program

Nanoparticles take aim at COVID-19 with lysosome-targeted delivery

Researchers discuss the use of endo-lysosome-targeted nanoparticles for delivering antiviral therapy to treat coronavirus infections.

Image-credit , Broadcast-media , Coronavirus-disease-covid-19 , Anoparticles , Ars , Ars-cov-2 , Ssay , Ell , Hloroquine , Oronavirus , Ovid-19

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

Researchers highlighted the pace of development of COVID-19 therapies during the pandemic and the challenges that hinder the widespread availability of anticoronavirals.

United-states , Japan , Viacheslav-lopatin-shutterstock , National-institutes-of-health , Drug-administration , Melinda-gates-foundation , Treatment-guidelines-panel , Nature-microbiology , Middle-east , National-institutes , Emergency-use-authorization , United-states-food

Early use of dexamethasone associated with reduced mortality in hospitalized COVID-19 requiring breathing support

In a recent study published in the journal JAMA Network Open, researchers examined the clinical use of dexamethasone for hospitalized patients with coronavirus disease 2019 (COVID-19) respiratory illness and explored the heterogeneity of treatment outcomes across different subgroups.

United-states , International-classification-of-diseases , National-cohort , Academia-research-generation-consortium , National-institute-of-health , World-health-organization , Inpatients-with , Image-credit , National-institute , Randomized-evaluation , Academia-research-generation